amrinone has been researched along with Bone Loss, Osteoclastic in 2 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Excerpt | Relevance | Reference |
---|---|---|
"Because stimulated bone resorption has been proposed to require Na-Ca exchange, we examined the effects of amrinone on bone." | 1.26 | Interaction between amrinone and parathyroid hormone on bone in culture. ( Krieger, NS; Stern, PH, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krieger, NS | 2 |
Stern, PH | 2 |
Stathopoulos, VM | 1 |
2 other studies available for amrinone and Bone Loss, Osteoclastic
Article | Year |
---|---|
Interaction between amrinone and parathyroid hormone on bone in culture.
Topics: Aminopyridines; Amrinone; Animals; Animals, Newborn; Bone and Bones; Bone Resorption; Calcitonin; Ca | 1982 |
Does amrinone inhibition of stimulated bone resorption involve Na+-Ca++ exchange?
Topics: Aminopyridines; Amrinone; Animals; Bone Resorption; Calcium; Cardiotonic Agents; Cycloheximide; Dact | 1986 |